ABBOTT LABORATORIES .

Abbott Laboratories may be slightly undervalued, yet its Healthy Food Rx expansion and digital‑integration strategy could unlock long‑term growth beyond diagnostics and devices.

Abbott’s new Libre Duo dual‑sensor glucose‑ketone system could curb rising DKA rates, especially in teens, by catching early signs before costly hospital stays.